In
this study, marine medaka (Oryzias melastigma) were
chronically exposed for 28 days to environmentally realistic
concentrations of 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one
(DCOIT) (0, 0.76, 2.45, and 9.86 μg/L), the active ingredient
in commercial antifouling agent SeaNine 211. Alterations of the hypothalamus-pituitary–gonadal-liver
(HPGL) axis were investigated across diverse levels of biological
organization to reveal the underlying mechanisms of its endocrine
disruptive effects. Gene transcription analysis showed that DCOIT
had positive regulatory effects mainly in male HPGL axis with lesser
extent in females. The stimulated steroidogenic activities resulted
in increased concentrations of steroid hormones, including estradiol
(E2), testosterone (T), and 11-KT-testosterone (11-KT),
in the plasma of both sexes, leading to an imbalance in hormone homeostasis
and increased E2/T ratio. The relatively estrogenic intracellular
environment in both sexes induced the hepatic synthesis and increased
the liver and plasma content of vitellogenin (VTG) or choriogenin.
Furthermore, parental exposure to DCOIT transgenerationally impaired
the viability of offspring, as supported by a decrease in hatching
and swimming activity. Overall, the present results elucidated the
estrogenic mechanisms along HPGL axis for the endocrine disruptive
effects of DCOIT. The reproductive impairments of DCOIT at environmentally
realistic concentrations highlights the need for more comprehensive
investigations of its potential ecological risks.